NEW YORK (GenomeWeb News) – Shares of Cepheid fell as low as $14.67 in Wednesday trade on the Nasdaq, nearing a 52-week low of $14.27.
 
The stock fell following a downgrade from investment bank Piper Jaffray from “Buy” to “Neutral.”
 
Cepheid’s shares were down 2.5 percent at $15.45 in early afternoon trade. The firm’s stock is down 41 percent since the beginning of the year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.